Emergent BioSolutions to lay off about 400 employees
(Reuters) – Emergent BioSolutions on Tuesday decided to cut 400 jobs and scale back operations at some its facilities, pivoting its focus on core products such as overdose reversal nasal spray Narcan and anthrax vaccines. The company said it will reduce operations at Bayview, Baltimore and Canton, Massachusetts, and do away with the chief operating…
